ANIMAL EXPERIMENT;
ARTICLE;
BIODEGRADABILITY;
CONTROLLED DRUG RELEASE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DRUG CONJUGATION;
DRUG DELIVERY SYSTEM;
DRUG PURIFICATION;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
EMULSION;
GEL PERMEATION CHROMATOGRAPHY;
LIGHT SCATTERING;
LYMPHOCYTE ACTIVATION;
MALE;
MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SCANNING ELECTROCHEMICAL MICROSCOPY;
STRUCTURE ANALYSIS;
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen
R.B. Nussenblatt Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen J. Immunol. 144 5 1990 1689 1695
(1990)J. Immunol., vol.144, Issue.5, pp. 1689-1695
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin
Z.J. Zhang Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin Proc. Natl. Acad. Sci. U. S. A. 88 22 1991 10252 10256
Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance
J.B. Sun, J. Holmgren, and C. Czerkinsky Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance Proc. Natl. Acad. Sci. U. S. A. 91 23 1994 10795 10799
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis
J.M. Stuart Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis J. Exp. Med. 155 1 1982 1 16
Oral type II collagen treatment in early rheumatoid arthritis. a double-blind, placebo-controlled, randomized trial
J. Sieper Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial Arthritis Rheum. 39 1 1996 41 51
Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: A novel treatment strategy for induction of oral tolerance
W.U. Kim Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance Arthritis Rheum. 46 4 2002 1109 1120
Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen
E.F. Rosloniec Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen J. Immunol. 160 6 1998 2573 2578
(1998)J. Immunol., vol.160, Issue.6, pp. 2573-2578
Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2 q mice
D.D. Brand Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2 q mice J. Immunol. 152 6 1994 3088 3097
(1994)J. Immunol., vol.152, Issue.6, pp. 3088-3097
Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis
H.Y. Kim Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis Arthritis Rheum. 42 10 1999 2085 2093
Suppression of reaginic antibodies with modified allergens: I. Reduction in allergenicity of protein allergens by conjugation to polyethylene glycol
W.Y. Lee, and A.H. Sehon Suppression of reaginic antibodies with modified allergens: I. Reduction in allergenicity of protein allergens by conjugation to polyethylene glycol Int. Arch. Allergy Appl. Immunol. 56 2 1978 159 170
Tolerance induction in mice by conjugates of monoclonal immunoglobulins and monomethoxypolyethylene glycol. Transfer of tolerance by T cells and by T cell extracts
I. Wilkinson Tolerance induction in mice by conjugates of monoclonal immunoglobulins and monomethoxypolyethylene glycol. Transfer of tolerance by T cells and by T cell extracts J. Immunol. 139 2 1987 326 331
Prevention of collagen-induced arthritis (CIA) by treatment with polyethylene glycol-conjugated type II collagen; Distinct tolerogenic property of the conjugated collagen from the native one
H.O. Ito Prevention of collagen-induced arthritis (CIA) by treatment with polyethylene glycol-conjugated type II collagen; distinct tolerogenic property of the conjugated collagen from the native one Clin. Exp. Immunol. 108 2 1997 213 219
Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres
G.D. Rosa Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres J. Control. Release 69 2 2000 283 295
Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres
T.H. Kim, H. Lee, and T.G. Park Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres Biomaterials 23 11 2002 2311 2317
(2002)Biomaterials, vol.23, Issue.11, pp. 2311-2317
Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction
E. Lubberts Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction J. Immunol. 163 8 1999 4546 4556
(1999)J. Immunol., vol.163, Issue.8, pp. 4546-4556